MOLECULAR TUMOR BOARD
GenomOncology’s Molecular Tumor Board enables clinicians to make treatment decisions through a fully integrated workflow that provides alteration-specific content matched to the patient's molecular and clinical history. Clinicians can create, edit, and present cases during a Molecular Tumor Board meeting, creating a final report to include in a patient's EHR record. With the ability to be implemented on-premise or in the cloud, the GenomOncology Molecular Tumor Board can automate your Tumor Board process and provide relevant, meaningful content to inform a patient's treatment plan.
Enhance clinical decision support in a molecular tumor board setting, or at the point of care.
STREAMLINE THE MOLECULAR TUMOR BOARD PROCESS
GenomOncology's Molecular Tumor Board solution eliminates the time-consuming, often manual process associated with setting up and running a molecular tumor board. Our innovative Molecular Tumor Board solution streamlines your meeting process and creates efficiencies to allow you to focus on patient care.
WHAT WE ENABLE YOU TO DO
AUTOMATING YOUR WORKFLOW
Our tool easily integrates with your clinical data warehouse to extract all relevant case-level, non-molecular information. We can combine this information with molecular data to automatically create cases that can be easily analyzed and reviewed.
Our tool can also automatically generate cases upon receiving new files from vendors through Secure File Transfer Protocol (SFTP). It differentiates between vendors and assays for comprehensive variant processing.
Our solution enables you to capture case-level recommendations to be able to export or send out to EHR systems. Our flexible reporting tools enable you to create case summaries, meeting summaries, and Molecular Tumor Board presentations.